Real-time enrollment status for this specific advanced solid tumors clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:30 AM UTC
| NCT Number | NCT06667141 |
| Recruiting Status | Recruiting |
| Condition | Specific Advanced Solid Tumors |
| Phase | Clinical Trial |
| Target Enrollment | 100 participants |
| Active Locations | 15 sites in the US |
| Sponsor | Acrivon Therapeutics |
| Last Updated on CT.gov | March 23, 2026 (Mar 23, 2026) |
As of July 13, 2026: Clinical trial NCT06667141 is currently recruiting participants. This clinical trial study for specific advanced solid tumors is actively seeking new participants at 15 locations across the United States. The study is sponsored by Acrivon Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06667141 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06667141 was last updated Mar 23, 2026 (March 23, 2026). HelloStudys verifies this status automatically.